NM_000251.3(MSH2):c.2100A>G (p.Ala700=) AND Lynch syndrome
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Feb 5, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003998601.2
Allele description [Variation Report for NM_000251.3(MSH2):c.2100A>G (p.Ala700=)]
NM_000251.3(MSH2):c.2100A>G (p.Ala700=)
Condition(s)
- Name:
- Lynch syndrome
- Identifiers:
- MONDO: MONDO:0005835; MedGen: C4552100
-
Homo sapiens asparagine synthetase (glutamine-hydrolyzing) (ASNS), transcript va...
Homo sapiens asparagine synthetase (glutamine-hydrolyzing) (ASNS), transcript variant 3, mRNAgi|1890346190|ref|NM_183356.4|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024